Intermolecular (IMI) Reports In-Line Q2 EPS

Intermolecular (NASDAQ: IMI) reported Q2 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $9.8 million versus the consensus estimate of $10 million.

GUIDANCE:

Intermolecular sees Q3 2018 EPS of ($0.03)-($0.05), versus the consensus of $0.01. Intermolecular sees Q3 2018 revenue of $6.5-7.5 million, versus the consensus of $9.95 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Barclays sees limited ECB reserve requirement impact on banks
• Equifax agrees to buy Mexican credit bureau for $750M